12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MIV-711: Phase I started

Medivir began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral MIV-711 in about 66 healthy volunteers. The trial will evaluate single-ascending doses of...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >